Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversing the Effects of 0.5% Bupivacaine: A Randomized Controlled Trial

NCT02995291 is registered in ClinicalTrials.gov with Dalhousie University as lead sponsor.

NCT NCT02995291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02995291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversing the Effects of 0.5% Bupivacaine: A Randomized Controlled Trial
Lead sponsor
Dalhousie University
Phase
Phase 4
Overall status
Completed
Start date
February 10, 2017
Completion date
September 15, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, local